Initial Experience With Viabahn VBX as the Bridging Stent Graft for Branched and Fenestrated Endovascular Aneurysm Repair

Abstract

Purpose:

To evaluate the feasibility and safety of a novel balloon-expandable, heparin-bonded endoprosthesis (Viabahn VBX, W. L. Gore and Associates) when used as a bridging stent graft (BSG) with fenestrated and branched endovascular aneurysm repair (FB-EVAR). FB-EVAR and BSGs increase repair complexity with the potential for endoleak formation, stenosis, thrombosis, and graft migration. The mechanical construction of the Viabahn VBX and its antithrombogenic properties may provide an advantage for FB-EVAR over existing BSGs. The efficacy, safety, and clinical outcomes were assessed.

Materials and Methods:

Research ethics board approved, prospective, single arm cohort, pilot study of patients undergoing FB-EVAR between February 2017 and January 2018. Fenestrated and branched endovascular aneurysm repair was performed per the standard institutional protocol by a team composed of vascular surgeons and interventional radiologists. Viabahn VBX endografts were used for all intended visceral branches as long as appropriately sized devices were available (Under Investigational Testing Authorization from Health Canada). Patient characteristics, procedural details, and technical and clinical outcomes were reviewed and summarized.

Results:

FB-EVAR was performed in 13 patients (9 male and 4 female) mean age of 74 (range: 61-83) with a total of 41 Viabahn VBXs stents implanted. Mean maximum aneurysm size was 6.7 cm (range: 5.5-9.0 cm) and included 5 juxtarenal abdominal aortic aneurysms and 8 thoracoabdominal; 3 type V, 3 type IV, and 2 type III (Crawford Classification). The Viabahn VBX was successfully deployed in 40 (98%) of 41 of cases. At median follow-up of 223 days (range: 2-462), there was a (40/40) 100% Viabahn VBX patency rate. Seven endoleaks were identified intra- or post procedurally in 6 (46%) of 13 cases, including 1 type IB, 3 type II, 2 type III, and 1 unclassified. Nine complications occurred in 6 patients.

Conclusion:

The Viabahn VBX stent is a safe and effective BSG for FB-EVAR with no early stent thrombosis. Further evaluation is required to determine longer term stent efficacy.

Keywords

endovascular aneurysm bridging stent graft Viabahn VBX

Get full access to this article

View all access options for this article.

References

Browne

Hartley

Purchas

Rosenberg

Van Schie

Lawrence-Brown

. A fenestrated covered suprarenal aortic stent. Eur J Vasc Endovasc Surg. 1999;18(5):445–449.

Verhoeven

ELG

Katsargyris

Oikonomou

Kouvelos

Renner

Ritter

. Fenestrated endovascular aortic aneurysm repair as a first line treatment option to treat short necked, juxtarenal, and suprarenal aneurysms. Eur J Vasc Endovasc Surg. 2016;51(6):775–781.

Grimme

FAB

Zeebregts

Verhoeven

ELG

Bekkema

Reijnen

MMJP

Tielliu

IFJ

. Visceral stent patency in fenestrated stent grafting for abdominal aortic aneurysm repair. J Vasc Surg. 2014;59(2):298–306.

Premprabha

Sobel

Pua

. Visceral branch occlusion following aneurysm repair using multibranched thoracoabdominal stent-grafts. J Endovasc Ther. 2014;21(6):783–790.

Panuccio

Bisdas

Berekoven

Torsello

Austermann

. Performance of bridging stent grafts in fenestrated and branched aortic endografting. Eur J Vasc Endovasc Surg. 2015;50(1):60–70.

Mendes

Oderich

. Selection of optimal bridging stents for fenestrations and branches. In: Endovascular Aortic Repair [Internet]. Cham, Switzerland: Springer; 2017:595. https://link.springer.com/chapter/10.1007/978-3-319-15192-2_25. Accessed February 19, 2018.

Bismuth

Gray

Holden

Metzger

Panneton

; VBX FLEX Study Investigators. Pivotal study of a next-generation balloon-expandable stent-graft for treatment of iliac occlusive disease. J Endovasc Ther. 2017;24(5):629–637.

Holden

Merrilees

Buckley

Connor

Colgan

Hill

. First-in-human experience with the gore balloon-expandable covered endoprosthesis in iliac artery occlusive disease. J Endovasc Ther. 2017;24(1):11–18.

FDA. PMA P160021: FDA Summary of Safety and Effectiveness Data: GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis [Internet]. FDA; 2017. https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160021B.pdf. Accessed April 2, 2018.

10.

Dindo

Demartines

Clavien

P-A

. Classification of surgical complications. Ann Surg. 2004;240(2):205–213.

11.

Mastracci

Carrell

Constantinou

. Editor’s Choice—Effect of branch stent choice on branch-related outcomes in complex aortic repair. Eur J Vasc Endovasc Surg. 2016;51(4):536–542.

12.

Liu

C-W

Jiang

Han

Liu

. Fenestrated endovascular repair for pararenal abdominal aortic aneurysms: a systematic review and meta-analysis. Ann Vasc Surg. 2013;27(8):1190–1200.

13.

Draney

Zarins

Taylor

. Three-dimensional analysis of renal artery bending motion during respiration. J Endovasc Ther. 2005;12(3):380–386.

14.

Suh

G-Y

Choi

Herfkens

Dalman

Cheng

. Respiration-induced deformations of the superior mesenteric and renal arteries in patients with abdominal aortic aneurysms. J Vasc Interv Radiol. 2013;24(7):1035–1042.

15.

Takemura

Suzuki

Sakamoto

. Analysis of respiration-related movement of upper abdominal arteries: preliminary measurement for the development of a respiratory motion compensation technique of roadmap navigation. Radiol Phys Technol. 2008;1(2):178–182.

16.

Maurel

Hertault

Gonzalez

. Evaluation of visceral artery displacement by endograft delivery system insertion. J Endovasc Ther. 2014;21(2):339–347.

17.

Beillas

Lafon

Smith

. The effects of posture and subject-to-subject variations on the position, shape and volume of abdominal and thoracic organs. Stapp Car Crash J. 2009;53:127–154.

18.

Howes

Hardy

Beillas

. The effects of cadaver orientation on the relative position of the abdominal organs. Ann Adv Automot Med. 2013;57:209–224.

19.

Rhyne

Gayzik

Moreno

Stitzel

. Methods for comparison of abdominal organ location and shape in the supine and upright positions. Biomed Sci Instrum. 2012;48:351–358.

20.

Hayes

Gayzik

Moreno

Martin

Stitzel

. Comparison of organ location, morphology, and rib coverage of a midsized male in the supine and seated positions [Internet]. Comput Math Methods Med. 2013. https://www.hindawi.com/journals/cmmm/2013/419821/. Accessed March 1, 2018.

21.

Lindholt

Gottschalksen

Johannesen

. The Scandinavian Propaten(®) trial—1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses—a randomised clinical controlled multi-centre trial. Eur J Vasc Endovasc Surg. 2011;41(5):668–673.

22.

Saxon

Chervu

Jones

. Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial. J Vasc Interv Radiol. 2013;24(2):165–173; quiz 174.

23.

Freeman

Chen

Weinberg

Okada

Chen

Lin

. Sustained thromboresistant bioactivity with reduced intimal hyperplasia of heparin-bonded polytetrafluoroethylene propaten graft in a chronic canine femoral artery bypass model. Ann Vasc Surg. 2018;49:295–303.

24.

Shemesh

Goldin

Hijazi

. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access. J Vasc Surg. 2015;62(1):115–122.

25.

Roy

Millen

Jones

. Long-term follow-up of fenestrated endovascular repair for juxtarenal aortic aneurysm. Br J Surg. 2017;104(8):1020–1027.

26.

Anton

Stahlberg

Horn

. Initial experience with the E-ventus® stentgraft for endovascular treatment of visceral artery aneurysms. J Cardiovasc Surg (Torino). 2018;59(2):225–231.